𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levetiracetam Intravenous Infusion: A Randomized, Placebo-controlled Safety and Pharmacokinetic Study

✍ Scribed by Steven Ramael; Agnès Daoust; Christian Otoul; Nathalie Toublanc; Mona Troenaru; Zhihong (Sarah) Lu; Armel Stockis

Book ID
109108961
Publisher
Wiley (Blackwell Publishing)
Year
2006
Tongue
English
Weight
203 KB
Volume
47
Category
Article
ISSN
0013-9580

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of perampanel in adv
Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo-controlled study
✍ Karla Eggert; David Squillacote; Paolo Barone; Richard Dodel; Regina Katzenschla 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Squillacote, received compensation from Eisai for their site's conduct of the study. Drs. Barone, Lees, and Oertel received honoraria from Eisai as members of the Advisory Board of this study. Dr. Rascol has received unrestricted scientific grant and honoraria from Eisai for his advice to the compan

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease
✍ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s

Levetiracetam in primary orthostatic tre
Levetiracetam in primary orthostatic tremor: A double-blind placebo-controlled crossover study
✍ Helge Hellriegel; Jan Raethjen; G. Deuschl; Jens Volkmann 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views

## Abstract ## Background: In a double‐blind crossover study we evaluated the antitremor effect of a 4‐week treatment with either escalating dosages of levetiracetam or placebo in orthostatic tremor. ## Methods: Twelve patients with orthostatic tremor participated in the study. Primary end point